Feb 15, 2024 · 30 min
Business
The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
- 416 episodes
- Updated Thursday
Episodes416
- Feb 8, 2024 · 32 min
293: AI in medicine, detangling hype, and Icelandic DNA
- Feb 1, 2024 · 35 min
292: Vertex's polarizing data, Aduhelm's adieu, & an FDA icon
- Jan 25, 2024 · 31 min
291: The plight of the VC, Gilead's latest setback, & more M&A
- Jan 18, 2024 · 42 min
290: Biotech layoffs, slumping stocks, and a 2024 preview
- Jan 11, 2024 · 28 min
289: Live! From #JPM24
- Dec 21, 2023 · 27 min
287: 2023 in review, CEO report cards, and a look at the year ahead
- Dec 14, 2023 · 34 min
286: FTC v. biotech, Pfizer's kitchen sink, & Vertex's future
- Dec 7, 2023 · 36 min
285: CRISPR history, biotech struggles, & a big week for deals
- Nov 30, 2023 · 28 min
284: AbbVie’s big deal, CAR-T’s risks, & getting a biotech job
- Nov 16, 2023 · 30 min
283: A CRISPR milestone, algorithms amok, & biotech mixology
- Nov 13, 2023 · 29 min
From Tradeoffs: Can the U.S. put an end to surprise ambulance bills?
- Nov 9, 2023 · 37 min
282: Lilly’s obesity drug, the power of radiation, & a biotech implosion
- Nov 2, 2023 · 32 min
281: Decoding biotech hype, the Sarepta saga, & au revoir to a CEO
- Oct 26, 2023 · 29 min
280: ESMO highlights, Roivant's big deal, & biotech VC on the rise
- Oct 19, 2023 · 33 min
279: Live from the 2023 STAT Summit
Oct 12, 2023 · 32 min278: Merger Mondays, Ozempic panic, & CRISPR'd pigs
Oct 5, 2023 · 31 min277: Is the Nobel committee evolving? Plus, preventing public health's wiliest virus
Sep 28, 2023 · 34 min276: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech's slump
Sep 21, 2023 · 33 min275: A thorny ALS debate at the FDA, and the promise of artificial wombs